Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 33 Observational 1

Sponsor

Cancer Type

Conditions

Glioma 3 Brain Neoplasms 2 Pituitary Neoplasms 1 Non-Melanoma Skin Cancer (NMSC) 1 Neuroectodermal Tumors 1 Neoplasms, Neuroepithelial 1 Neoplasms 1 Neoplasm, Residual 1 Keratosis, Actinic 1 Central Nervous System Neoplasms 1

Interventions

3-ingenyl angelate 5 Imiquimod 4 methyl 5-aminolevulinate 2 Tomography, Optical Coherence 2 tirbanibulin 1 Surveys and Questionnaires 1 Solutions 1 Microarray Analysis 1 Fluorouracil 1 Diclofenac 1 Biopsy 1 Aminolevulinic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Keratosis, Actinic × Aminolevulinic Acid × Clear all

NCT02209012 2016-09-23

Twelve Month Follow-Up of CP0108

DUSA Pharmaceuticals, Inc.

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡